Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 138

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 5
Chunk 138
---
 for the year attributable to owners of the Company                    ¥                                              144.1      ¥                                      ¥                                    ¥                                    ¥                                     ¥  

___________

Notes:

(1) Others: finance income (expenses), net includes the loss on non-monetary items for subsidiaries in hyperinflationary economies and for which IAS29, Financial Reporting in Hyperinflationary Economies, is applied, and finance income and expense related to non-core transactions; share of profit (loss) of investments accounted for using the equity method includes gains and losses associated with divestments and liquidations, and other fair value adjustments.

(2) Taxes on the adjustments between IFRS Accounting Standards and core results, take into account the statutory tax rate applicable to the item based upon the jurisdiction where the adjustment is recorded. Total income tax expense on core adjustments (JPY 866.0 billion) to profit before tax was JPY 253.3 billion, resulting in an average tax rate of 29.2% on core adjustments.

Table of Contents

                                                                                   For the Year Ended March 31, 2023                                                                                                                                                                                     
                                                                                   Reported                                       Amortization of intangible assets      Impairment of intangible assets      Other operating income/expenses      Others (1)      Core Financial Measures               
                                                                                   (IFRS)                                                                                                                                                                          (non-IFRS)                            
                                                                                   (billions of yen, except for percentages)                                                                                                                                                                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Operating profit                                                                 ¥                                              ¥                                      ¥                                    ¥                                    ¥               ¥                            1,188.4  
  Operating margin                                                                 12.2                                           —                                      —                                    —                                    —               29.5                                  
  Finance income (expenses), net                                                   (106.8)                                        —                                      —                                    —                                    (19.8)          (126.6)                               
  Share of profit (loss) of investments accounted for using the equity method      (8.6)                                          —                                      —                                    —                                    8.8             0.2                                   
  Profit before tax                                                                375.1                                          485.1                                  57.3                                 119.8                                24.6                                         1,062.0  
  Income tax (expenses) benefit (2)                                                (58.1)                                         (103.5)                                (12.5)